This is a Validated Antibody Database (VAD) review about dogs CLDN3, based on 20 published articles (read how Labome selects the articles), using CLDN3 antibody in all methods. It is aimed to help Labome visitors find the most suited CLDN3 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Invitrogen
domestic rabbit polyclonal
  • immunohistochemistry; human; 1:200; loading ...; fig 3c
Invitrogen CLDN3 antibody (Invitrogen, 34-1700) was used in immunohistochemistry on human samples at 1:200 (fig 3c). Science (2020) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; dogs; fig 2
  • western blot; dogs; fig 2
In order to study the role of claudin-4 in tight junctions in MDCK cells, Invitrogen CLDN3 antibody (Invitrogen, 34-1700) was used in immunocytochemistry on dogs samples (fig 2) and in western blot on dogs samples (fig 2). PLoS ONE (2017) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; fig 1
  • western blot; human; 1:1000; fig 1
  • western blot; rat; 1:1000; fig 1
In order to examine claudin-11 localization in testis of patients with normal and impaired spermatogenesis, Invitrogen CLDN3 antibody (Invitrogen, 34-1700) was used in western blot on mouse samples at 1:1000 (fig 1), in western blot on human samples at 1:1000 (fig 1) and in western blot on rat samples at 1:1000 (fig 1). PLoS ONE (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; loading ...; fig s1a
In order to use transgenic mice to clarify the role of LKB1 in the maintenance of functional tight junction, Invitrogen CLDN3 antibody (Thermo Fisher, 34-1700) was used in immunohistochemistry on mouse samples (fig s1a). Hepatology (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; mouse; 1:150; fig s8
In order to analyze preservation of epithelial polarity and epithelial barrier by alix-mediated assembly of the actomyosin-tight junction polarity complex, Invitrogen CLDN3 antibody (Life Technologies, 34-1,700) was used in immunohistochemistry - frozen section on mouse samples at 1:150 (fig s8). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; mouse; 1:200
  • western blot; mouse; 1:1000; fig 5
In order to assess the transiently formed junctional nexuses during post-natal mammary gland development by E-cadherins, connexins, beta-catenin, and claudin-7, Invitrogen CLDN3 antibody (Life Technologies, 34-1700) was used in immunohistochemistry - frozen section on mouse samples at 1:200 and in western blot on mouse samples at 1:1000 (fig 5). Dev Biol (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; fig 5
In order to study the favored formation of polarized salivary acinar-like structures by the role of human fibronectin- or placenta basement membrane extract-based gels, Invitrogen CLDN3 antibody (Zymed, 34-1700) was used in immunocytochemistry on human samples (fig 5). J Tissue Eng Regen Med (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; fig 1
In order to characterize induction of lactation-specific tight junctions concurrent with beta-casein expression in mammary epithelial cells due to prolactin and glucocorticoid signaling, Invitrogen CLDN3 antibody (Life Technologies, 34-1700) was used in immunohistochemistry - paraffin section on mouse samples (fig 1). Biochim Biophys Acta (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; mouse; 10 ug/ml; fig 2
In order to study a model of immune functions of the mouse blood-cerebrospinal fluid barrier in vitro using primary epithelial cells better suited to study immune cell migration across the brain barrier, Invitrogen CLDN3 antibody (Invitrogen, 341700) was used in immunocytochemistry on mouse samples at 10 ug/ml (fig 2). Fluids Barriers CNS (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:500; fig 2
In order to analyze the transition from epithelial-mesenchymal induced by transforming growth factor beta, Invitrogen CLDN3 antibody (Zymed, 341700) was used in western blot on human samples at 1:500 (fig 2). Methods Mol Biol (2016) ncbi
domestic rabbit polyclonal
In order to characterize two clones from triple negative breast MDA-MB-231 cancer cells, Invitrogen CLDN3 antibody (Invitrogen, 34-1700) was used . Exp Cell Res (2015) ncbi
domestic rabbit polyclonal
In order to investigate the contribution of claudin-3 to breast cancer, Invitrogen CLDN3 antibody (Life Technologies, 34-1700) was used . Oncol Lett (2015) ncbi
domestic rabbit polyclonal
In order to discuss how the fungal toxin deoxynivalenol may contribute to inflammatory bowel disease, Invitrogen CLDN3 antibody (Invitrogen, 34-1700) was used . J Nutr (2015) ncbi
domestic rabbit polyclonal
In order to propose that claudin-4 is required for mAChR-modulated paracellular permeability of epithelial cells and investigate the mechanism, Invitrogen CLDN3 antibody (Life Technologies, 341700) was used . J Cell Sci (2015) ncbi
domestic rabbit polyclonal
In order to investigate the role of claudin-1/claudin-5 in epithelial/endothelial barriers, Invitrogen CLDN3 antibody (Life Technologies, 34-1700) was used . Biomaterials (2015) ncbi
domestic rabbit polyclonal
  • western blot; mouse
In order to demonstrate that miR-200 suppresses TGF-beta/BMP signaling, promotes epithelial gene expression, and suppresses cell invasion by regulating a network of genes, Invitrogen CLDN3 antibody (Life Technologies, 341700) was used in western blot on mouse samples . Oncogene (2016) ncbi
domestic rabbit polyclonal
In order to characterize TALEN-mediated claudin-2 knockout in MDCK cells, Invitrogen CLDN3 antibody (Invitrogen, 34-1700) was used . PLoS ONE (2015) ncbi
domestic rabbit polyclonal
In order to evaluate the diagnostic value of intestinal fatty acid binding protein for intra-abdominal pressure-related complications, Invitrogen CLDN3 antibody (Zymed Laboratories, 34-1700) was used . Scand J Trauma Resusc Emerg Med (2015) ncbi
domestic rabbit polyclonal
In order to investigate the effect of homoharringtonine on intestinal epithelial permeability and its mechanism, Invitrogen CLDN3 antibody (Invitrogen, 34-1700) was used . Eur J Pharm Biopharm (2015) ncbi
domestic rabbit polyclonal
In order to study tight-junction proteins in human proximal small intestinal mucosa before and after Roux-en-Y gastric bypass surgery, Invitrogen CLDN3 antibody (Invitrogen, 34-1700) was used . Surg Obes Relat Dis (2015) ncbi
Articles Reviewed
  1. Pellegrini L, Bonfio C, Chadwick J, Begum F, Skehel M, Lancaster M. Human CNS barrier-forming organoids with cerebrospinal fluid production. Science. 2020;: pubmed publisher
  2. Tokuda S, Hirai T, Furuse M. Claudin-4 knockout by TALEN-mediated gene targeting in MDCK cells: Claudin-4 is dispensable for the permeability properties of tight junctions in wild-type MDCK cells. PLoS ONE. 2017;12:e0182521 pubmed publisher
  3. Stammler A, Lüftner B, Kliesch S, Weidner W, Bergmann M, Middendorff R, et al. Highly Conserved Testicular Localization of Claudin-11 in Normal and Impaired Spermatogenesis. PLoS ONE. 2016;11:e0160349 pubmed publisher
  4. Porat Shliom N, Tietgens A, Van Itallie C, Vitale Cross L, Jarnik M, Harding O, et al. Liver kinase B1 regulates hepatocellular tight junction distribution and function in vivo. Hepatology. 2016;64:1317-29 pubmed publisher
  5. Campos Y, Qiu X, Gomero E, Wakefield R, Horner L, Brutkowski W, et al. Alix-mediated assembly of the actomyosin-tight junction polarity complex preserves epithelial polarity and epithelial barrier. Nat Commun. 2016;7:11876 pubmed publisher
  6. Dianati E, Poiraud J, Weber Ouellette A, Plante I. Connexins, E-cadherin, Claudin-7 and ?-catenin transiently form junctional nexuses during the post-natal mammary gland development. Dev Biol. 2016;416:52-68 pubmed publisher
  7. Maria O, Liu Y, El Hakim M, Zeitouni A, Tran S. The role of human fibronectin- or placenta basement membrane extract-based gels in favouring the formation of polarized salivary acinar-like structures. J Tissue Eng Regen Med. 2017;11:2643-2657 pubmed publisher
  8. Kobayashi K, Tsugami Y, Matsunaga K, Oyama S, Kuki C, Kumura H. Prolactin and glucocorticoid signaling induces lactation-specific tight junctions concurrent with ?-casein expression in mammary epithelial cells. Biochim Biophys Acta. 2016;1863:2006-16 pubmed publisher
  9. Lazarevic I, Engelhardt B. Modeling immune functions of the mouse blood-cerebrospinal fluid barrier in vitro: primary rather than immortalized mouse choroid plexus epithelial cells are suited to study immune cell migration across this brain barrier. Fluids Barriers CNS. 2016;13:2 pubmed publisher
  10. Valcourt U, Carthy J, Okita Y, Alcaraz L, Kato M, Thuault S, et al. Analysis of Epithelial-Mesenchymal Transition Induced by Transforming Growth Factor β. Methods Mol Biol. 2016;1344:147-81 pubmed publisher
  11. Martínez Revollar G, Garay E, Martín Tapia D, Nava P, Huerta M, Lopez Bayghen E, et al. Heterogeneity between triple negative breast cancer cells due to differential activation of Wnt and PI3K/AKT pathways. Exp Cell Res. 2015;339:67-80 pubmed publisher
  12. Todd M, Petty H, King J, Piana Marshall B, Sheller R, Cuevas M. Overexpression and delocalization of claudin-3 protein in MCF-7 and MDA-MB-415 breast cancer cell lines. Oncol Lett. 2015;10:156-162 pubmed
  13. Akbari P, Braber S, Alizadeh A, Verheijden K, Schoterman M, Kraneveld A, et al. Galacto-oligosaccharides Protect the Intestinal Barrier by Maintaining the Tight Junction Network and Modulating the Inflammatory Responses after a Challenge with the Mycotoxin Deoxynivalenol in Human Caco-2 Cell Monolayers and B6C3F1 Mice. J Nutr. 2015;145:1604-13 pubmed publisher
  14. Cong X, Zhang Y, Li J, Mei M, Ding C, Xiang R, et al. Claudin-4 is required for modulation of paracellular permeability by muscarinic acetylcholine receptor in epithelial cells. J Cell Sci. 2015;128:2271-86 pubmed publisher
  15. Staat C, Coisne C, Dabrowski S, Stamatovic S, Andjelkovic A, Wolburg H, et al. Mode of action of claudin peptidomimetics in the transient opening of cellular tight junction barriers. Biomaterials. 2015;54:9-20 pubmed publisher
  16. Perdigão Henriques R, Petrocca F, Altschuler G, Thomas M, Le M, Tan S, et al. miR-200 promotes the mesenchymal to epithelial transition by suppressing multiple members of the Zeb2 and Snail1 transcriptional repressor complexes. Oncogene. 2016;35:158-72 pubmed publisher
  17. Tokuda S, Furuse M. Claudin-2 knockout by TALEN-mediated gene targeting in MDCK cells: claudin-2 independently determines the leaky property of tight junctions in MDCK cells. PLoS ONE. 2015;10:e0119869 pubmed publisher
  18. Strang S, van Waes O, van der Hoven B, Ali S, Verhofstad M, Pickkers P, et al. Intestinal fatty acid binding protein as a marker for intra-abdominal pressure-related complications in patients admitted to the intensive care unit; study protocol for a prospective cohort study (I-Fabulous study). Scand J Trauma Resusc Emerg Med. 2015;23:6 pubmed publisher
  19. Watari A, Hashegawa M, Yagi K, Kondoh M. Homoharringtonine increases intestinal epithelial permeability by modulating specific claudin isoforms in Caco-2 cell monolayers. Eur J Pharm Biopharm. 2015;89:232-8 pubmed publisher
  20. Casselbrant A, Elias E, Fändriks L, Wallenius V. Expression of tight-junction proteins in human proximal small intestinal mucosa before and after Roux-en-Y gastric bypass surgery. Surg Obes Relat Dis. 2015;11:45-53 pubmed publisher